Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2017

Open Access 01-12-2017 | Research article

Impact of chronic Pseudomonas aeruginosa infection on health-related quality of life in Mycobacterium avium complex lung disease

Authors: Hirofumi Kamata, Takanori Asakura, Shoji Suzuki, Ho Namkoong, Kazuma Yagi, Yohei Funatsu, Satoshi Okamori, Shunsuke Uno, Yoshifumi Uwamino, Hiroshi Fujiwara, Tomoyasu Nishimura, Makoto Ishii, Tomoko Betsuyaku, Naoki Hasegawa

Published in: BMC Pulmonary Medicine | Issue 1/2017

Login to get access

Abstract

Background

In bronchiectasis patients, chronic Pseudomonas aeruginosa (PA) infection has been associated with worse health-related quality of life (HRQL), but little is known about Mycobacterium avium complex lung disease (MACLD) patients in this context. This study aimed to evaluate HRQL and investigate the impact of chronic PA infection in MACLD patients.

Methods

This cross-sectional study was conducted using the Registry of Prospective Cohort Study including MACLD patients. The 36-item Short-Form health survey (SF-36) and St. George’s Respiratory Questionnaire (SGRQ) were administered to assess clinical outcomes. Clinical variables included treatment and sputum culture status, pulmonary function tests, cavitary lesions, and modified Reiff scores on high-resolution computed tomography.

Results

The study included 244 MACLD patients (median age, 68 years; 196 women), 19 of whom had chronic PA infection. Modified Reiff score was higher in patients with chronic infection than in those without (P = 0.028). Regarding SF-36 scores, physical functioning subscale scores were significantly lower in patients with chronic infection (P = 0.029). Additionally, SGRQ symptoms, impact, and total scores were significantly higher in patients with chronic infection. During analysis of covariance comparisons, SGRQ symptoms and impact scores were significantly higher for patients with chronic infection (P = 0.043 and 0.021, respectively).

Conclusions

MACLD patients with chronic PA infection exhibited significantly higher SGRQ scores, indicating impaired HRQL. Chronic PA infection was significantly associated with the severity of bronchiectasis.
Literature
1.
go back to reference Prevots DR, Marras TK. Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review. Clin Chest Med. 2015;36(1):13–34.CrossRefPubMed Prevots DR, Marras TK. Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review. Clin Chest Med. 2015;36(1):13–34.CrossRefPubMed
2.
go back to reference Namkoong H, Kurashima A, Morimoto K, Hoshino Y, Hasegawa N, Ato M, et al. Epidemiology of pulmonary nontuberculous mycobacterial disease, Japan. Emerg Infect Dis. 2016;22(6):1116–7.CrossRefPubMedPubMedCentral Namkoong H, Kurashima A, Morimoto K, Hoshino Y, Hasegawa N, Ato M, et al. Epidemiology of pulmonary nontuberculous mycobacterial disease, Japan. Emerg Infect Dis. 2016;22(6):1116–7.CrossRefPubMedPubMedCentral
3.
go back to reference Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175(4):367–416.CrossRefPubMed Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175(4):367–416.CrossRefPubMed
5.
go back to reference Lee BY, Kim S, Hong Y, Lee SD, Kim WS, Kim DS, et al. Risk factors for recurrence after successful treatment of Mycobacterium avium Complex lung disease. Antimicrob Agents Chemother. 2015;59(6):2972–7.CrossRefPubMedPubMedCentral Lee BY, Kim S, Hong Y, Lee SD, Kim WS, Kim DS, et al. Risk factors for recurrence after successful treatment of Mycobacterium avium Complex lung disease. Antimicrob Agents Chemother. 2015;59(6):2972–7.CrossRefPubMedPubMedCentral
6.
go back to reference Satta G, McHugh TD, Mountford J, Abubakar I, Lipman M. Managing pulmonary nontuberculous mycobacterial infection. Time for a patient-centered approach. Ann Am Thorac Soc. 2014;11(1):117–21.CrossRefPubMedPubMedCentral Satta G, McHugh TD, Mountford J, Abubakar I, Lipman M. Managing pulmonary nontuberculous mycobacterial infection. Time for a patient-centered approach. Ann Am Thorac Soc. 2014;11(1):117–21.CrossRefPubMedPubMedCentral
7.
go back to reference McShane PJ, Naureckas ET, Tino G, Strek ME. Non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med. 2013;188(6):647–56.CrossRefPubMed McShane PJ, Naureckas ET, Tino G, Strek ME. Non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med. 2013;188(6):647–56.CrossRefPubMed
8.
go back to reference McDonnell MJ, Aliberti S, Goeminne PC, Dimakou K, Zucchetti SC, Davidson J, et al. Multidimensional severity assessment in bronchiectasis: an analysis of seven European cohorts. Thorax. 2016;71(12):1110–8.CrossRefPubMedPubMedCentral McDonnell MJ, Aliberti S, Goeminne PC, Dimakou K, Zucchetti SC, Davidson J, et al. Multidimensional severity assessment in bronchiectasis: an analysis of seven European cohorts. Thorax. 2016;71(12):1110–8.CrossRefPubMedPubMedCentral
9.
go back to reference Lonni S, Chalmers JD, Goeminne PC, McDonnell MJ, Dimakou K, De Soyza A, et al. Etiology of non-cystic fibrosis bronchiectasis in adults and its correlation to disease severity. Ann Am Thorac Soc. 2015;12(12):1764–70.CrossRefPubMedPubMedCentral Lonni S, Chalmers JD, Goeminne PC, McDonnell MJ, Dimakou K, De Soyza A, et al. Etiology of non-cystic fibrosis bronchiectasis in adults and its correlation to disease severity. Ann Am Thorac Soc. 2015;12(12):1764–70.CrossRefPubMedPubMedCentral
10.
go back to reference Mirsaeidi M, Hadid W, Ericsoussi B, Rodgers D, Sadikot RT. Non-tuberculous mycobacterial disease is common in patients with non-cystic fibrosis bronchiectasis. Int J Infect Dis. 2013;17(11):e1000–4.CrossRefPubMedPubMedCentral Mirsaeidi M, Hadid W, Ericsoussi B, Rodgers D, Sadikot RT. Non-tuberculous mycobacterial disease is common in patients with non-cystic fibrosis bronchiectasis. Int J Infect Dis. 2013;17(11):e1000–4.CrossRefPubMedPubMedCentral
11.
go back to reference Wallace RJ Jr, Brown-Elliott BA, McNulty S, Philley JV, Killingley J, Wilson RW, et al. Macrolide/Azalide therapy for nodular/bronchiectatic Mycobacterium avium Complex lung disease. Chest. 2014;146(2):276–82.CrossRefPubMedPubMedCentral Wallace RJ Jr, Brown-Elliott BA, McNulty S, Philley JV, Killingley J, Wilson RW, et al. Macrolide/Azalide therapy for nodular/bronchiectatic Mycobacterium avium Complex lung disease. Chest. 2014;146(2):276–82.CrossRefPubMedPubMedCentral
12.
go back to reference Lee G, Lee KS, Moon JW, Koh WJ, Jeong BH, Jeong YJ, et al. Nodular bronchiectatic Mycobacterium avium Complex pulmonary disease. Natural course on serial computed tomographic scans. Ann Am Thorac Soc. 2013;10(4):299–306.CrossRefPubMed Lee G, Lee KS, Moon JW, Koh WJ, Jeong BH, Jeong YJ, et al. Nodular bronchiectatic Mycobacterium avium Complex pulmonary disease. Natural course on serial computed tomographic scans. Ann Am Thorac Soc. 2013;10(4):299–306.CrossRefPubMed
13.
go back to reference Finch S, McDonnell MJ, Abo-Leyah H, Aliberti S, Chalmers JDA. Comprehensive analysis of the impact of Pseudomonas aeruginosa colonization on prognosis in adult bronchiectasis. Ann Am Thorac Soc. 2015;12(11):1602–11.PubMed Finch S, McDonnell MJ, Abo-Leyah H, Aliberti S, Chalmers JDA. Comprehensive analysis of the impact of Pseudomonas aeruginosa colonization on prognosis in adult bronchiectasis. Ann Am Thorac Soc. 2015;12(11):1602–11.PubMed
14.
go back to reference Fujita K, Ito Y, Hirai T, Kubo T, Togashi K, Ichiyama S, et al. Prevalence and risk factors for chronic co-infection in pulmonary Mycobacterium avium Complex disease. BMJ Open Respir Res. 2014;1(1):e000050.CrossRefPubMedPubMedCentral Fujita K, Ito Y, Hirai T, Kubo T, Togashi K, Ichiyama S, et al. Prevalence and risk factors for chronic co-infection in pulmonary Mycobacterium avium Complex disease. BMJ Open Respir Res. 2014;1(1):e000050.CrossRefPubMedPubMedCentral
15.
go back to reference Fukuhara S, Bito S, Green J, Hsiao A, Kurokawa K. Translation, adaptation, and validation of the SF-36 health survey for use in Japan. J Clin Epidemiol. 1998;51(11):1037–44.CrossRefPubMed Fukuhara S, Bito S, Green J, Hsiao A, Kurokawa K. Translation, adaptation, and validation of the SF-36 health survey for use in Japan. J Clin Epidemiol. 1998;51(11):1037–44.CrossRefPubMed
16.
go back to reference Jones PW, Quirk FH, Baveystock CM, Littlejohns PA. Self-complete measure of health status for chronic airflow limitation. The St. George’s respiratory questionnaire. Am Rev Respir Dis. 1992;145(6):1321–7.CrossRefPubMed Jones PW, Quirk FH, Baveystock CM, Littlejohns PA. Self-complete measure of health status for chronic airflow limitation. The St. George’s respiratory questionnaire. Am Rev Respir Dis. 1992;145(6):1321–7.CrossRefPubMed
17.
go back to reference Asakura T, Funatsu Y, Ishii M, Namkoong H, Yagi K, Suzuki S, et al. Health-related quality of life is inversely correlated with C-reactive protein and age in Mycobacterium avium Complex lung disease: a cross-sectional analysis of 235 patients. Respir Res. 2015;16:145.CrossRefPubMedPubMedCentral Asakura T, Funatsu Y, Ishii M, Namkoong H, Yagi K, Suzuki S, et al. Health-related quality of life is inversely correlated with C-reactive protein and age in Mycobacterium avium Complex lung disease: a cross-sectional analysis of 235 patients. Respir Res. 2015;16:145.CrossRefPubMedPubMedCentral
18.
go back to reference Suzukamo Y, Fukuhara S, Green J, Kosinski M, Gandek B, Ware JE. Validation testing of a three-component model of short Form-36 scores. J Clin Epidemiol. 2011;64(3):301–8.CrossRefPubMed Suzukamo Y, Fukuhara S, Green J, Kosinski M, Gandek B, Ware JE. Validation testing of a three-component model of short Form-36 scores. J Clin Epidemiol. 2011;64(3):301–8.CrossRefPubMed
19.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CRA. New method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.CrossRefPubMed Charlson ME, Pompei P, Ales KL, MacKenzie CRA. New method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.CrossRefPubMed
20.
go back to reference Ueyama M, Asakura T, Morimoto K, Namkoong H, Matsuda S, Osawa T, et al. Pneumothorax associated with nontuberculous mycobacteria: a retrospective study of 69 patients. Medicine (Baltimore). 2016;95(29):e4246.CrossRefPubMedCentral Ueyama M, Asakura T, Morimoto K, Namkoong H, Matsuda S, Osawa T, et al. Pneumothorax associated with nontuberculous mycobacteria: a retrospective study of 69 patients. Medicine (Baltimore). 2016;95(29):e4246.CrossRefPubMedCentral
21.
go back to reference Chalmers JD, Goeminne P, Aliberti S, McDonnell MJ, Lonni S, Davidson J, et al. The bronchiectasis severity index. An international derivation and validation study. Am J Respir Crit Care Med. 2014;189(5):576–85.CrossRefPubMedPubMedCentral Chalmers JD, Goeminne P, Aliberti S, McDonnell MJ, Lonni S, Davidson J, et al. The bronchiectasis severity index. An international derivation and validation study. Am J Respir Crit Care Med. 2014;189(5):576–85.CrossRefPubMedPubMedCentral
22.
go back to reference Khurana S, Ravi A, Sutula J, Milone R, Williamson R, Plumb J, et al. Clinical characteristics and airway inflammation profile of COPD persistent sputum producers. Respir Med. 2014;108(12):1761–70.CrossRefPubMed Khurana S, Ravi A, Sutula J, Milone R, Williamson R, Plumb J, et al. Clinical characteristics and airway inflammation profile of COPD persistent sputum producers. Respir Med. 2014;108(12):1761–70.CrossRefPubMed
23.
go back to reference Desai H, Eschberger K, Wrona C, Grove L, Agrawal A, Grant B, et al. Bacterial colonization increases daily symptoms in patients with chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2014;11(3):303–9.CrossRefPubMed Desai H, Eschberger K, Wrona C, Grove L, Agrawal A, Grant B, et al. Bacterial colonization increases daily symptoms in patients with chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2014;11(3):303–9.CrossRefPubMed
24.
go back to reference Simpson JL, Baines KJ, Horvat JC, Essilfie AT, Brown AC, Tooze M, et al. COPD is characterized by increased detection of Haemophilus influenzae, Streptococcus pneumoniae and a deficiency of Bacillus species. Respirology. 2016;21(4):697–704.CrossRefPubMed Simpson JL, Baines KJ, Horvat JC, Essilfie AT, Brown AC, Tooze M, et al. COPD is characterized by increased detection of Haemophilus influenzae, Streptococcus pneumoniae and a deficiency of Bacillus species. Respirology. 2016;21(4):697–704.CrossRefPubMed
25.
go back to reference Wilson CB, Jones PW, O'Leary CJ, Hansell DM, Cole PJ, Wilson R. Effect of sputum bacteriology on the quality of life of patients with bronchiectasis. Eur Respir J. 1997;10(8):1754–60.CrossRefPubMed Wilson CB, Jones PW, O'Leary CJ, Hansell DM, Cole PJ, Wilson R. Effect of sputum bacteriology on the quality of life of patients with bronchiectasis. Eur Respir J. 1997;10(8):1754–60.CrossRefPubMed
26.
go back to reference Chen AC, Martin ML, Lourie R, Rogers GB, Burr LD, Hasnain SZ, et al. Adult non-cystic fibrosis bronchiectasis is characterised by airway luminal Th17 pathway activation. PLoS One. 2015;10(3):e0119325.CrossRefPubMedPubMedCentral Chen AC, Martin ML, Lourie R, Rogers GB, Burr LD, Hasnain SZ, et al. Adult non-cystic fibrosis bronchiectasis is characterised by airway luminal Th17 pathway activation. PLoS One. 2015;10(3):e0119325.CrossRefPubMedPubMedCentral
27.
go back to reference Hector A, Kroner C, Carevic M, Bakele M, Rieber N, Riethmuller J, et al. The chemokine CCL18 characterises Pseudomonas infections in cystic fibrosis lung disease. Eur Respir J. 2014;44(6):1608–15.CrossRefPubMed Hector A, Kroner C, Carevic M, Bakele M, Rieber N, Riethmuller J, et al. The chemokine CCL18 characterises Pseudomonas infections in cystic fibrosis lung disease. Eur Respir J. 2014;44(6):1608–15.CrossRefPubMed
28.
go back to reference Dimakou K, Triantafillidou C, Toumbis M, Tsikritsaki K, Malagari K, Bakakos P. Non CF-bronchiectasis: Aetiologic approach, clinical, radiological, microbiological and functional profile in 277 patients. Respir Med. 2016;116:1–7.CrossRefPubMed Dimakou K, Triantafillidou C, Toumbis M, Tsikritsaki K, Malagari K, Bakakos P. Non CF-bronchiectasis: Aetiologic approach, clinical, radiological, microbiological and functional profile in 277 patients. Respir Med. 2016;116:1–7.CrossRefPubMed
29.
go back to reference Faverio P, Stainer A, Bonaiti G, Zucchetti SC, Simonetta E, Lapadula G, et al. Characterizing non-tuberculous mycobacteria infection in bronchiectasis. Int J Mol Sci. 2016;17(11):E1913.CrossRefPubMed Faverio P, Stainer A, Bonaiti G, Zucchetti SC, Simonetta E, Lapadula G, et al. Characterizing non-tuberculous mycobacteria infection in bronchiectasis. Int J Mol Sci. 2016;17(11):E1913.CrossRefPubMed
30.
go back to reference Asakura T, Yamada Y, Namkoong H, Suzuki S, Niijima Y, Kamata H, et al. Impact of cavity and infiltration on pulmonary function and health-related quality of life in pulmonary Mycobacterium avium Complex disease: a 3-dimensional computed tomographic analysis. Respir Med. 2017;126:9–16.CrossRefPubMed Asakura T, Yamada Y, Namkoong H, Suzuki S, Niijima Y, Kamata H, et al. Impact of cavity and infiltration on pulmonary function and health-related quality of life in pulmonary Mycobacterium avium Complex disease: a 3-dimensional computed tomographic analysis. Respir Med. 2017;126:9–16.CrossRefPubMed
31.
go back to reference Gochi M, Takayanagi N, Kanauchi T, Ishiguro T, Yanagisawa T, Sugita Y. Retrospective study of the predictors of mortality and radiographic deterioration in 782 patients with nodular/bronchiectatic Mycobacterium avium Complex lung disease. BMJ Open. 2015;5(8):e008058.CrossRefPubMedPubMedCentral Gochi M, Takayanagi N, Kanauchi T, Ishiguro T, Yanagisawa T, Sugita Y. Retrospective study of the predictors of mortality and radiographic deterioration in 782 patients with nodular/bronchiectatic Mycobacterium avium Complex lung disease. BMJ Open. 2015;5(8):e008058.CrossRefPubMedPubMedCentral
32.
go back to reference Takeda K, Imamura Y, Takazono T, Yoshida M, Ide S, Hirano K, et al. The risk factors for developing of chronic pulmonary aspergillosis in nontuberculous mycobacteria patients and clinical characteristics and outcomes in chronic pulmonary aspergillosis patients coinfected with nontuberculous mycobacteria. Med Mycol. 2016;54(2):120–7.CrossRefPubMed Takeda K, Imamura Y, Takazono T, Yoshida M, Ide S, Hirano K, et al. The risk factors for developing of chronic pulmonary aspergillosis in nontuberculous mycobacteria patients and clinical characteristics and outcomes in chronic pulmonary aspergillosis patients coinfected with nontuberculous mycobacteria. Med Mycol. 2016;54(2):120–7.CrossRefPubMed
33.
go back to reference Song JW, Koh WJ, Lee KS, Lee JY, Chung MJ, Kim TS, et al. High-resolution CT findings of Mycobacterium avium-Intracellulare Complex pulmonary disease: correlation with pulmonary function test results. AJR Am J Roentgenol. 2008;191(4):1070.CrossRefPubMed Song JW, Koh WJ, Lee KS, Lee JY, Chung MJ, Kim TS, et al. High-resolution CT findings of Mycobacterium avium-Intracellulare Complex pulmonary disease: correlation with pulmonary function test results. AJR Am J Roentgenol. 2008;191(4):1070.CrossRefPubMed
34.
go back to reference Binder AM, Adjemian J, Olivier KN, Prevots DR. Epidemiology of nontuberculous mycobacterial infections and associated chronic macrolide use among persons with cystic fibrosis. Am J Respir Crit Care Med. 2013;188(7):807–12.CrossRefPubMedPubMedCentral Binder AM, Adjemian J, Olivier KN, Prevots DR. Epidemiology of nontuberculous mycobacterial infections and associated chronic macrolide use among persons with cystic fibrosis. Am J Respir Crit Care Med. 2013;188(7):807–12.CrossRefPubMedPubMedCentral
35.
go back to reference Bar-On O, Mussaffi H, Mei-Zahav M, Prais D, Steuer G, Stafler P, et al. Increasing nontuberculous mycobacteria infection in cystic fibrosis. J Cyst Fibros. 2015;14(1):53–62.CrossRefPubMed Bar-On O, Mussaffi H, Mei-Zahav M, Prais D, Steuer G, Stafler P, et al. Increasing nontuberculous mycobacteria infection in cystic fibrosis. J Cyst Fibros. 2015;14(1):53–62.CrossRefPubMed
36.
go back to reference Aksamit TR, O'Donnell AE, Barker A, Olivier KN, Winthrop KL, Daniels ML, et al. Adult bronchiectasis patients: a first look at the United States bronchiectasis research registry. Chest. 2016;151(5):982–92.CrossRefPubMed Aksamit TR, O'Donnell AE, Barker A, Olivier KN, Winthrop KL, Daniels ML, et al. Adult bronchiectasis patients: a first look at the United States bronchiectasis research registry. Chest. 2016;151(5):982–92.CrossRefPubMed
37.
go back to reference Hwang JA, Kim S, Jo KW, Shim TS. Natural history of Mycobacterium avium complex lung disease in untreated patients with stable course. Eur Respir J. 2017;49(3):1600537. Hwang JA, Kim S, Jo KW, Shim TS. Natural history of Mycobacterium avium complex lung disease in untreated patients with stable course. Eur Respir J. 2017;49(3):1600537.
Metadata
Title
Impact of chronic Pseudomonas aeruginosa infection on health-related quality of life in Mycobacterium avium complex lung disease
Authors
Hirofumi Kamata
Takanori Asakura
Shoji Suzuki
Ho Namkoong
Kazuma Yagi
Yohei Funatsu
Satoshi Okamori
Shunsuke Uno
Yoshifumi Uwamino
Hiroshi Fujiwara
Tomoyasu Nishimura
Makoto Ishii
Tomoko Betsuyaku
Naoki Hasegawa
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2017
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-017-0544-x

Other articles of this Issue 1/2017

BMC Pulmonary Medicine 1/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.